Temasek - Heliconia Capital - Ron Sim - Jumbo Group

Temasek Holdings unit Heliconia Capital Management is targeting local enterprises that wish to expand abroad demonstrated by its recent cornerstone investment in local food and beverage multi-dining concept brand Jumbo Group.

Jumbo Group surged in its trading debut after selling shares in the city-state’s largest initial public offering (IPO) to date for 2015. The IPO was backed by cornerstone investors Heliconia and Osim International’s chairman and founder Ron Sim. Initially offered at S$0.25, the shares rose as much as 58 per cent to an intra-day high of S$0.395.

Jumbo operates restaurants offering pork rib soup, or bak kut teh,  as well as ramen noodles. It claims to serve more than 6000 customers daily, according to its website. A filing indicates its plans to expand abroad and deepen its footprint in Singapore with the opening of four more outlets in China and Singapore within 2016-2017 period.

Heliconia describes itself as an investment firm that focuses on growth-oriented Singapore firms, as well as investing directly into Singapore-focused private equity (PE) funds as a limited partner (LP). According to their Bloomberg profile, the funds that Heliconia infuses capital into mandates investment of at least 50 per cent of committed capital into Singapore-based ventures.

In an interaction with Bloomberg, CEO Derek Lau explained: “For Heliconia, our mandate is to identify and support Singapore-headquartered companies to be globally competitive companies. We will continue with a steady pace of investment.”

Heliconia took a S$10-million holding in Jumbo’s IPO, according to a filing by Jumbo Group. According to Lau, the Temasek unit has invested in about nine ventures focused on urbanisation and the growing middle class in the region.

Publicly available information on their website indicates a portfolio of nine ventures that includes Singapore-based gaming hardware manufacturer Razer, MRO offshore solutions provider Mencast and engineering solutions architect and provider Hope Technik, which was reported by Tech in Asia to be exploring swarm intelligence applications for drones in 2014.

In a statement to Bloomberg, Lau said, “We’re careful. We have no set targets; it depends on when the opportunities arise. There’s no fixed formula. We need the stars to be aligned. Obviously the companies themselves must see the value that Heliconia can bring.”

Also Read: Temasek unit, OSIM founder come in as cornerstone investors in seafood chain Jumbo Group’s IPO

http://www.dealstreetasia.com/stories/temasek-unit-heliconia-capital-bets-on-singapore-growth-ventures-looking-to-turn-global-18929/

Enspire - Chay Kwong Soon

The Enspire Group is a technology and business development group that assists the inspired entrepreneurs to achieve their vision and dreams to build long-lasting and highly differentiating business. Founded and led by veteran entrepreneur,

Mr Chay Kwong Soon, co-founder of Creative Technology Ltd and Chairman of Beyonics Technology Ltd, the Enspire team provides, besides financial investment, value-add to our portfolio companies through our extensive network, experience and expertise.

Enspire works with companies that are in the fast growing fields of communication, internet and medical technology.

Enspire participates in any stage of the company's growth, though our valueadd would be greatest in the early stages.

Since incorporation in 1998, Enspire has invested in more than 20 companies in Singapore, Taiwan, US and Europe.  

http://ftp.antlabs.com/index.php?option=com_content&view=article&id=58%3Ainvestor-profile&catid=38&Itemid=105

Golden Energy and Resources (GEAR) new name for United Fiber System

Just completed $1.88 billion reverse takeover exercise by a Sinar Mas related entity

Name change effective 21st April 2015

Reverse Take Over (RTO) completed 20th April 2015

New business will now focus on

1. Coal mining

2. Forestry

3. Trading businesses of GEAR post-RTO


226.5 million share placement will be conducted

Tommie Goh Thiam Poh - 2G Capital

1. Chairman of 2G Capital, a private investment company

2. Founded JIT Holdings in 1988 , a Singapore contract electronics manufacturer

3. Awarded the Public Service Medal in 2002

4. Conferred the Doctor of Philosophy by Wisconsin International University in 2000

5. Sold JIT to Flextronics November 2000 in a $640 million stock deal. Former Board Member at Flextronics International Ltd.

6. Spent $3.7 million on a 68th-storey unit in Tower 1 of The Sail @ Marina Bay a waterfront lifestyle condominium located in the Marina Bay area in Singapore.

7. Continues to invest in companies in Asia Pacific and is supportive of the study of entrepreneurship.

8. In 2000, donated $2m to establish the The Tommie Goh Professorial Chair in Entrepreneurship and Business at SMU.

9. Listed as the 19th largest shareholder in the Midas Holdings 2014 Annual Report

Blue Sky Power Holdings Ltd (SGX:UQ7)

Description

Blue Sky Power Holdings Limited, formerly China Print Power Group Limited, is an investment holding company. The Company is a books and specialized products printing company serving the international market. The Company specialize in the printing of books, as well as the design and manufacturing of quality specialized products, such as leather and fabric-bound diaries, journals and greeting cards. Its integrated services include pre-press, printing to finishing/binding services. The Company's segments include book product, which is engaged in the provision of suite of services from pre-press to printing to finishing/ binding services, and specialized product, which is engaged in the production of custom-made printing products. The Company serves a base of customers that includes international publishers and retail stores across Europe, North America and Asia, such as Barnes & Noble Distribution in the United States, Parragon Books Ltd. in the United Kingdom, and others.

More from Reuters »

 

http://www.google.com/finance?cid=714746701970440

SGX Healthcare Stocks - Five largest capitalised health-care equipment and services stocks

1. IHH Healthcare

2. Raffles Medical Group (RMG)

3. Biosensors International Group

4. Religare Health Trust

5.  TalkMed Group

IHH Healthcare

 Key growth markets with operations and investments in our home markets of Singapore, Malaysia and Turkey.

Key markets of the People's Republic of China, India and Hong Kong; as well as in other markets such as Brunei, Vietnam, United Arab Emirates ("the UAE"), Macedonia and Iraq.

World's second-largest listed healthcare operator by market capitalisation.

On 25 July 2012, IHH's initial public offering ("IPO") became the first ever IPO to be simultaneously listed on the main markets of Bursa Malaysia Securities Berhad ("Bursa Securities") and Singapore Exchange Securities Trading Limited ("the SGX-ST"). Deemed a major step in creating greater cooperation amongst regional bourses, the Group's dual listing was the largest ever IPO for a hospital operator in Asia, the second largest IPO in Asia for 2012 and the third largest IPO in the world for the same year.

Today, IHH's business units operate over 6,000 licensed beds in 37 hospitals as well as medical centres, clinics and ancillary healthcare businesses across ten countries, with over 3,000 new beds in the pipeline to be delivered through new hospital developments and expansion of existing facilities. We employ more than 25,000 people worldwide.

Our "Mount Elizabeth", "Gleneagles", "Pantai" and "Acibadem" brands are among the most prestigious in Asia and Central and Eastern Europe, with a growing presence in the Middle East. Each IHH-invested company is a premium brand operating in an established and growing home market and, in a number of cases, with significant inbound medical tourism growth potential.

http://www.ihhhealthcare.com/index.php

Raffles Medical Group (RMG)

Raffles Medical Group (RMG), (Chinese: 莱佛士医疗集团) (SGX: R01) established in 1976. The group runs a network of clinics, hospitals, surgical centres, speciality units and medical laboratories islandwide.

In 1976, the group's founders, Dr Loo Choon Yong and Dr Alfred Loh opened their first two clinics in Singapore's Central Business District (CBD) with the aim of providing medical services to corporate clients. By 1989, this had grown to five clinics and it was then that the two friends decided to incorporate their clinics into a medical practice group. Expanding after its incorporation, RMG moved into Singapore's HDB heartlands with their first neighbourhood clinic in 1993. More similar clinics soon followed in other estates.

In 1990, RMG tendered and obtained a contract with the Civil Aviation Authority of Singapore to provide medical services to the passengers transiting through Changi International Airport as well as airport workers. This also marked RMG's first 24-hour clinic.

Today, RMG runs a network of 74 multi-disciplinary clinics across Singapore, and four medical centres in Hong Kong and Shanghai. Airport clinics in Singapore’s Changi International Airport and Hong Kong’s Chek Lap Kok International Airport are also managed by them.

The Group's flagship hospital is Raffles Hospital. It is located in Bugis and consists of 20 different specialist centres which provides specialist services such as obstetrics and gynaecology, cardiology, oncology and orthopaedics.^[1]

In 2005, RMG also began offering health financing under its subsidiary International Medical Insurers (IMI). RMG also has its own consumer healthcare division which develops and distributes a full range of nutraceuticals, supplements, vitamins and medical diagnostic equipment.

RMG uses the Institutional Group Practice Model. Through this model, specialists work as a team to provide patients quality medical services that are integrated, peer reviewed and medically audited.

http://en.wikipedia.org/wiki/Raffles_Medical_Group

Biosensors International Group

Since 1990, we have been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment.

Always seeking to be at the forefront of product innovation, we entered the interventional cardiology market in 2000 with our proprietary coronary stent and accompanying stent delivery system. In the same year, we further expanded our product line to include angioplasty balloons and catheters.

Since that time, Biosensors has rapidly grown to become the world’s fourth largest supplier of cardiac stents, with the BioMatrix™ family of drug-eluting stent and the Axxess™ self-expanding bifurcation stent.  Our pioneering work has continued with the development of the BioFreedom drug-coated stent, which received CE Mark approval in January 2013 and is currently available in selected markets.

The BioMatrix Family of drug-eluting stents incorporate Biolimus A9™ (BA9™), an anti-restenotic drug developed specifically for use with stents and patented by Biosensors, together with a unique abluminal biodegradable polymer coating, which fully degrades into carbon dioxide and water after six to nine months as it releases BA9. The latest addition to the BioMatrix Family, BioMatrix NeoFlex™, features an enhanced stent delivery system, bringing exceptional performance in complex lesions and challenging anatomies

The Axxess self-expanding dedicated bifurcation stent features the same winning combination of BA9 and biodegradable polymer with a conical shaped nitinol self-expanding stent platform, specifically designed to conform to the shape of the bifurcation anatomy.
BioFreedom features a microstructured abluminal surface, which permits the controlled release of BA9 without the use of a polymer or other carrier.

http://www.biosensors.com/intl/

Religare Health Trust

RHT is the first business trust listed on the SGX-ST with a portfolio comprising healthcare assets in India.

Our investment mandate is principally to invest in medical and healthcare assets in Asia, Australasia and emerging markets in the rest of the world.

The portfolio comprises 12 Clinical Establishments, 4 Greenfield Clinical Establishments and 2 Operating Hospitals. The total value of these assets are approximately S$844 million as at 30 September 2014.

The Trustee-Manger intends to pursue the following strategies in order to meet the key objective:

1. Acquisition Growth Strategy
   Source for and acquire assets, in accordance with RHT's investment mandate, with the objective of enhancing distributions to Unitholders.
2. Development Strategy
   Expand RHT's portfolio of medical and healthcare assets and services including through greenfield development projects.
3. Active Asset Management and Enhancement Strategy
   Implement pro-active measures to enhance the returns from RHT's existing and future portfolio in consultation with the current or prospective operator(s) of the assets.
4. Capital and Financial Risk Management Strategy
   Employ an appropriate mix of debt and equity in the financing of the acquisition of medical and healthcare assets and asset enhancements. The Trustee-Manager may also from time to time utilise interest rate and currency hedging strategies to manage the risks associated with changes to interest rate and currency fluctuations.

http://www.religarehealthtrust.com/

TalkMed Group

Premier provider of medical oncology and palliative care health care services in Singapore

We are a group of doctors providing tertiary healthcare services in the fields of medical oncology and palliative care to the oncology patients in the private sector in Singapore through PCC. Tertiary healthcare involves specialised care of a high complexity requiring specialised skills, personnel and support services. We have specialists with special interests in breast cancers, head and neck cancers,gastro-intestinal cancers, uro-gynaecological cancers, and haematology malignancies.

 

 

Executive Officers

Our Executive Officers as at the date of this Offer Document comprise our Executive Directors, Dr Ang Peng Tiam and Dr Khoo Kei Siong, and our CFO, Mr Quek Hiong How.

Information on the business and working experience, education and professional qualifications, if any, of our CFO are set out below:

Mr Quek Hiong How is our CFO and is responsible for overseeing the finance and accounting functions of our Group. He was the finance director of Boustead Projects Pte Ltd from October 2005 to July 2009, a subsidiary of Boustead Singapore Limited (an SGX-ST Mainboard-listed company) as well as the chief financial officer of Informatics Holdings Ltd (currently known as Informatics Education Ltd.) from October 2003 to September 2005.

Mr Quek was the chief financial officer for Keppel Communications and Transportation Ltd from February 2000 to June 2003. Mr Quek was also the Vice President (Finance and Administration) for the then-Television Corporation of Singapore Pte Ltd from 1993 to 2000.

Mr Quek is a member of the Institute of Singapore Chartered Accountants (formerly known as the Institute of Certified Public Accountants of Singapore) and a fellow of the Association of Chartered and Certified Accountants, United Kingdom.

http://www.talkmed.com.sg/

A Conceptual Approach to Singapore Taxation - Poh Eng Hin

Description



 A book on Singapore income taxation and the goods and services tax presented along the lines of a seven-point conceptual framework comprising:

(1) Jurisdiction;
(2) Base;
(3) Allocation;
(4) Person;
(5) Cross-Border Linkages;
(6) Tax Expenditures; and
(7) Administration.
General Information

 

Author: Poh Eng Hin / Deborah M.Y. Poh

(Special thanks to Ms Dora Lim for being the principal author of Appendix 23-1 of the book)

Institution author affiliated to: Nanyang Business School, Nanyang Technological University, Singapore...



(Disclaimer: The views expressed in the book are the author’s own and do not necessarily reflect those of any institution to which the author is affiliated. While every effort has been taken to ensure the accuracy and completeness of the publication, the author expressly disclaims liability for any loss that may occasion to any party from any reliance placed on the work.)

Publisher: Pearson Education

ISBN: 978-981-45-2698-2

Year of publication: 2013 (1st edition)

No. of pages (main content): 922



Table of Contents:

PART 1: INTRODUCTION AND THE CONCEPTUAL FRAMEWORK
Overview of Part 1
Chapter 1: Introduction to Taxation
Chapter 2: The Conceptual Framework and The Legal Framework
Chapter 3: The Conceptual Framework Applied to Income Taxation

PART 2: JURISDICTION
Overview of Part 2
Chapter 4: Defining the Income Tax Jurisdiction
Chapter 5: Defining Heads of Charge
Chapter 6: Determining the Residence of the Person
Chapter 7: Locating the Geographical Source of the Income

PART 3: BASE
Overview of Part 3
Chapter 8: Exemptions
Chapter 9: Deductions
Chapter 10: Capital Allowances
Chapter 11: Quantifying Statutory Income
Chapter 12: Quantifying Assessable Income
Chapter 13: Quantifying Chargeable Income

PART 4: PERSON
Overview of Part 4
Chapter 14: Income Tax Aspects Peculiar to Companies
Chapter 15: Income Tax Aspects Peculiar to Individuals
Chapter 16: Taxation of Partnership Income
Chapter 17: Taxation of Other Entities

PART 5: CROSS-BORDER LINKAGES
Overview of Part 5
Chapter 18: Double Taxation and Tax Treaties
Chapter 19: Residents Receiving Foreign Income in Singapore
Chapter 20: Non-Residents Deriving Singapore Income

PART 6: ALLOCATION
Overview of Part 6
Chapter 21: Further Allocation Issues

PART 7: ADMINISTRATION
Overview of Part 7
Chapter 22: Income Tax Administration

PART 8: TAX EXPENDITURES
Overview of Part 8
Chapter 23: Overview of Income Tax Incentives

PART 9: GOODS AND SERVICES TAX
Overview of Part 9
Chapter 24: Introduction to the GST
Chapter 25: GST in Singapore


ORDER / CONTACT DETAILS:
To order the book or to contact the author, please send a private message via this Facebook page.  


https://www.facebook.com/pages/A-Conceptual-Approach-to-Singapore-Taxation/515803501818636